Results 121 to 130 of about 404,062 (356)
Chronic Obstructive Pulmonary Disease (COPD) is a disease characterized by local and systemic inflammation independently of the risk factor; during the exacerbations, such inflammation is accentuated and amplified. A practical inflammatory marker and one
Juan Silva-Gallardo +5 more
doaj +1 more source
Dose-response and pharmacokinetic study with almitrine bismesylate after single oral administrations in COPD patients [PDF]
Thierry Bury +3 more
openalex +1 more source
COPD or functionally COPD? [PDF]
Duarte-de-Araújo A +2 more
openaire +1 more source
Objective The objective of this study was to compare the long‐term safety profiles of ocrelizumab and rituximab in persons with multiple sclerosis (MS). Methods Using retrospective data from the University of California (UC) Health System, we simulated a target clinical trial. The primary cohort from UC San Francisco (UCSF) and a validation cohort from
Gabriel Cerono +3 more
wiley +1 more source
Air quality in Mexico City during the COVID-19 lockdown possibly decreased COPD exacerbations
Francisco Montiel-Lopez +11 more
doaj +1 more source
Aim Drugs with anticholinergic effects are often considered as potentially inappropriate medications, especially for older patients, and deprescribing such drugs may improve cognitive function. The aim was to investigate the effectiveness of counselling on drug risks as part of a multimodal intervention to prevent cognitive decline. Methods The AgeWell.
Laura K. Lepenies +14 more
wiley +1 more source
Aims This study investigated factors associated with and outcomes of combined loop diuretics with hydrochlorothiazide (HCTZ) for acute decompensated heart failure (ADHF). Methods In this retrospective study, adults hospitalized for ADHF and who received intravenous loop diuretics between January 2016 and March 2023 were enrolled.
Chia‐Chen Hsu +6 more
wiley +1 more source
The disruptive effects of COPD exacerbation-associated factors on epithelial repair responses
IntroductionExacerbations of chronic obstructive pulmonary disease (COPD) increase mortality risk and can lead to accelerated loss of lung function. The increased inflammatory response during exacerbations contributes to worsening of airflow limitation ...
Rosa K. Kortekaas +12 more
doaj +1 more source
Ventilatory Effects of Beta-blockers and Characteristics of Patients with COPD [PDF]
A.P.M. Greefhorst, C.L.A. van Herwaarden
openalex +1 more source

